Monashee Investment Management
Monashee Investment Management reported 16 stocks worth $33.4M in its 13F filing for Q3 2026, filed Nov 6, 2026. Its largest holdings are AXON (14.8%), IMMX (14.0%) and SYY (12.8%). Compared with Q2 2026, the fund opened new positions in AXON, IMMX and SYY, trimmed ADT, SLDB and IMA and sold out of DLR, SYRE and TNGX.
Latest filing: what Monashee Investment Management did in Q3 2026
vs Q2 2026None
Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() AXON Axon Enterprise Inc | $4.9M | 14.8% | 5M | New position | 1 of 8 | |
| 2 | ![]() IMMX Immix Biopharma Inc | $4.7M | 14.0% | 450K | New position | 1 of 8 | |
| 3 | ![]() SYY Sysco Corp | $4.3M | 12.8% | 55K | New position | 1 of 8 | |
| 4 | ![]() NWCL Newcleo PLC | $3.1M | 9.4% | 400K | New position | 1 of 8 | |
| 5 | ![]() ADT Adt Inc Del | $3M | 9.1% | 500K | −100K (−17%) | 7 of 8 | |
| 6 | ![]() SLDB Solid Biosciences Inc | $3M | 8.9% | 410K | −90K (−18%) | 7 of 8 | |
| 7 | ![]() ENB Enbridge Inc F | $2.3M | 7.0% | 50K | New position | 1 of 8 | |
| 8 | ![]() VKTX Viking Therapeutics Inc | $1.5M | 4.6% | 1.5M | New position | 1 of 8 | |
| 9 | ![]() BLSM Blossomhill Therapeutics Inc | $1.5M | 4.5% | 80K | New position | 1 of 8 | |
| 10 | ![]() ETRA Electra Therapeutics Inc | $1.1M | 3.4% | 100K | New position | 1 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
ALPHABET INC | $5.1M | 100K |
ALPHABET INC | $5M | 100K |
![]() DLR Digital Rlty TR Inc | $4.5M | 25K |
![]() SYRE Spyre Therapeutics Inc | $4.4M | 50K |
![]() TNGX Tango Therapeutics Inc | $3.1M | 100K |
🔒 Free account: see all 17.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 6, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Monashee Investment Management 13F FAQ
What does Monashee Investment Management own?
Monashee Investment Management reported 16 stocks worth $33.4M in its 13F filing for Q3 2026, filed Nov 6, 2026. Its largest holdings are AXON (14.8%), IMMX (14.0%) and SYY (12.8%). The table above lists every position in the filing (the top 10 without an account).
What did Monashee Investment Management buy and sell in Q3 2026?
Compared with Q2 2026: 13 new positions, 0 added to, 3 trimmed and 17 sold out. New positions include AXON, IMMX and SYY. It sold all of DLR, SYRE and TNGX.
When will Monashee Investment Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Monashee Investment Management's portfolio worth?
The Q3 2026 filing reports $33.4M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.













